Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.59 |
| ▸ | FABP7 | O15540 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CASP3 | P42574 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | MDM4 | O15151 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29381061 | 1.00 | FABP5 (0.59) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL44677 | 1.00 | FABP5 (0.59) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL30433255 | 0.93 | KMT2A (0.55) | FABP5FABP7KMT2AEPHX2CA1 | |
| Isothiocyanate SCHEMBL29261606 | 0.90 | FABP5 (0.51) | FABP5FABP7KMT2AEPHX2CA1 | |
| Isothiocyanate SCHEMBL30858893 | 0.90 | FABP5 (0.51) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL44676 | 0.86 | KMT2A (0.58) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL15981181 | 0.86 | KMT2A (0.58) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL13258633 | 0.86 | FABP5 (0.51) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL7767154 | 0.86 | FABP5 (0.54) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL29598813 | 0.86 | FABP5 (0.54) | FABP5FABP7KMT2AEPHX2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4416284-A1 | EXTRA-HEPATIC DELIVERY IRNA COMPOSITIONS AND METHODS OF USE THEREOF | Alnylam Pharmaceuticals, Inc. (US) | 2024-08-21 | — | — | EP | claimed |
| WO-2023064530-A1 | EXTRA-HEPATIC DELIVERY IRNA COMPOSITIONS AND METHODS OF USE THEREOF | ALNYLAM PHARMACEUTICALS, INC. (US) | 2023-04-20 | — | — | WO | claimed |
| CN-119716077-A | Kit for analysis using nucleic acid encoding and/or labelling | ENCODIA公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119574874-A | Macromolecular analysis using nucleic acid encoding | ENCODIA公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119574873-A | Macromolecular analysis using nucleic acid encoding | ENCODIA公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-112272703-B | Kit for analysis using nucleic acid encoding and/or labelling | ENCODIA公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-110199019-B | Macromolecular analysis using nucleic acid encoding | ENCODIA有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-111163771-B | Use of pyrimidopyrimidinones as SIK inhibitors | 通用医疗公司 | 2023-07-14 | — | — | CN | disclosed |
| EP-4065715-A1 | SYNTHESIS OF 3'-RNA OLIGONUCLEOTIDES | Alnylam Pharmaceuticals, Inc. (US) | 2022-10-05 | — | — | EP | disclosed |